103 related articles for article (PubMed ID: 9499362)
1. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.
Khan A; Krishna M; Baker SP; Malhothra R; Banner BF
Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma.
Khan A; Krishna M; Baker SP; Banner BF
Mod Pathol; 1998 Aug; 11(8):704-8. PubMed ID: 9720496
[TBL] [Abstract][Full Text] [Related]
3. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
Mori M; Kohli A; Baker SP; Savas L; Fraire AE
Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
Inoue T; Ishida T; Sugio K; Sugimachi K
Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between laminin and fibronectin on the basement membrane and tumor progression in early gastric cancer: an immunohistochemical study].
Fujita J
Hokkaido Igaku Zasshi; 2000 Jan; 75(1):25-34. PubMed ID: 10736758
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B on invasion and metastasis of gastric carcinoma.
Liu Y; Xiao S; Shi Y; Wang L; Ren W; Sloane BF
Chin Med J (Engl); 1998 Sep; 111(9):784-8. PubMed ID: 11155666
[TBL] [Abstract][Full Text] [Related]
7. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
[TBL] [Abstract][Full Text] [Related]
9. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
12. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
15. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.
Scorilas A; Fotiou S; Tsiambas E; Yotis J; Kotsiandri F; Sameni M; Sloane BF; Talieri M
Biol Chem; 2002; 383(7-8):1297-303. PubMed ID: 12437120
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
17. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M
J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
19. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin B and human tumor progression.
Yan S; Sameni M; Sloane BF
Biol Chem; 1998 Feb; 379(2):113-23. PubMed ID: 9524062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
